Company Description
BioHarvest Sciences Inc. operates as a biotechnology company.
The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
The company is involved in research h, development, manufacturing, marketing and sales of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food, as well as manufacturing, marketing, and sales of science-based health and cosmeceutical solutions.
The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine.
The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
| Country | Canada |
| Founded | 2007 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 2 |
| CEO | Ilan Sobel |
Contact Details
Address: 1140-625 Howe Street Vancouver, BC V6C 2T6 Canada | |
| Phone | 604 689 5722 |
| Website | bioharvest.com |
Stock Details
| Ticker Symbol | BHST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001723464 |
| ISIN Number | CA09076J2074 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ilan Sobel | Chief Executive Officer |
| Dr. Zaki Rakib Ph.D. | Co-Founder, Executive Chairman and President |
| Dr. Yoheved Hagay Ph.D. | Co-Founder, Chief Technology Officer and Member of Scientific Advisory Board |
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| David K. Ryan | Vice President of Investor Relations and Secretary |
| Bar Dichter | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2025 | 6-K | Report of foreign issuer |
| Apr 1, 2025 | 6-K | Report of foreign issuer |
| Mar 31, 2025 | F-X | Filing |
| Mar 31, 2025 | 40-F | Filing |
| Mar 17, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Mar 4, 2025 | 6-K | Report of foreign issuer |
| Feb 18, 2025 | 6-K | Report of foreign issuer |
| Feb 14, 2025 | 6-K | Report of foreign issuer |
| Feb 12, 2025 | SCHEDULE 13G | Filing |